Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

17.49
-1.1000-5.92%
Volume:1.90M
Turnover:34.23M
Market Cap:2.99B
PE:-6.41
High:19.06
Open:18.77
Low:17.39
Close:18.59
Loading ...
Jun 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities